Back

Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection

Wei, J.; Alfajaro, M.; Hanna, R.; DeWeirdt, P.; Strine, M.; Lu-Culligan, W.; Zhang, S.-M.; Graziano, V.; Schmitz, C.; Chen, J.; Mankowski, M.; Filler, R.; Gasque, V.; de Miguel, F.; Chen, H.; Oguntuyo, K. Y.; Abriola, L.; Surovtseva, Y.; Orchard, R.; Lee, B.; Lindenbach, B.; Politi, K.; van Dijk, D.; Simon, M.; Yan, Q.; Doench, J. G.; Wilen, C. B.

2020-06-17 genetics
10.1101/2020.06.16.155101 bioRxiv
Show abstract

Identification of host genes essential for SARS-CoV-2 infection may reveal novel therapeutic targets and inform our understanding of COVID-19 pathogenesis. Here we performed a genome-wide CRISPR screen with SARS-CoV-2 and identified known SARS-CoV-2 host factors including the receptor ACE2 and protease Cathepsin L. We additionally discovered novel pro-viral genes and pathways including the SWI/SNF chromatin remodeling complex and key components of the TGF-{beta} signaling pathway. Small molecule inhibitors of these pathways prevented SARS-CoV-2-induced cell death. We also revealed that the alarmin HMGB1 is critical for SARS-CoV-2 replication. In contrast, loss of the histone H3.3 chaperone complex sensitized cells to virus-induced death. Together this study reveals potential therapeutic targets for SARS-CoV-2 and highlights host genes that may regulate COVID-19 pathogenesis.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.